Richard M. Van Rijn, Ph.D.
Affiliations: | 2013- | Medicinal Chemistry and Molecular Pharmacology | Purdue University, West Lafayette, IN, United States |
Area:
opioid receptors, addiction, alcoholismGoogle:
"Richard Van Rijn"Mean distance: 19.65 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Robert Verpoorte | research assistant | 2001-2002 | Leiden |
| Rob Leurs | grad student | 2002-2006 | VU Amsterdam (Chemistry Tree) |
| Jennifer L. Whistler | post-doc | 2007-2013 | UCSF |
Children
Sign in to add trainee| Robert Cassell | grad student | 2016- | Purdue |
| Mee Jung Ko | grad student | 2016- | Purdue |
| Arryn Blaine | grad student | 2018- | Purdue |
| Anna Gutridge | grad student | 2018- | Purdue |
| Yazan Meqbil | grad student | 2020- | Purdue |
| Doungkamol Alongkronrusmee | grad student | 2014-2018 | Purdue |
| Meridith T. Robins | grad student | 2014-2018 | Purdue |
| Alexander French | post-doc | 2019- | Purdue |
| Kamonchanok Sansuk | post-doc | 2013-2014 | Purdue |
| Terrance Chiang | research scientist | 2013-2016 | Purdue |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| French AR, Meqbil YJ, van Rijn RM. (2023) ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment. Frontiers in Pharmacology. 14: 1295518 |
| Blaine AT, van Rijn RM. (2023) Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures. Neuropharmacology. 109526 |
| Hennessy MR, Gutridge AM, French AR, et al. (2023) Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of Medicinal Chemistry |
| Blaine AT, Miao Y, Yuan J, et al. (2022) Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions. Frontiers in Pharmacology. 13: 914651 |
| Van Rijn RM, Spetea M. (2022) Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II. Molecules (Basel, Switzerland). 27 |
| French AR, Gutridge AM, Yuan J, et al. (2022) Sex- and β-arrestin-dependent effects of kappa opioid receptor-mediated ethanol consumption. Pharmacology, Biochemistry, and Behavior. 216: 173377 |
| French AR, van Rijn RM. (2022) An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects. Pharmacological Research. 177: 106091 |
| Meqbil YJ, Su H, Cassell RJ, et al. (2021) Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26 |
| Sharma KK, Cassell RJ, Meqbil YJ, et al. (2021) Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. Rsc Medicinal Chemistry. 12: 1958-1967 |
| Gutridge AM, Chakraborty S, Varga BR, et al. (2021) Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Frontiers in Pharmacology. 12: 764885 |